MEDICINE DETAILS
Retsevmo
Active ingredient: Selpercatinib
Neutral reference profile for an independent medicine-access consultancy enquiry about Retsevmo (Selpercatinib). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Retsevmo used for?
Retsevmo (selpercatinib) is a kinase inhibitor (chemotherapy) indicated for the treatment of:
- RET fusion-positive non-small cell lung cancer (NSCLC) that has spread (metastasized) in adults.
- Advanced or metastatic RET-mutant medullary thyroid cancer (MTC) requiring systemic therapy in patients aged 12 years and older.
- Advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy in patients aged 12 years and older, who have received radioactive iodine that did not work or is no longer working.
It is available in capsule form containing 40 mg or 80 mg of Retsevmo (selpercatinib). Retsevmo is the first therapy approved for patients with RET-driven tumors.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Retsevmo identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
40 mg · 56 capsules Catalogue organisation: LILLY DEUTSCHLAND GmbH
-
40 mg · 168 capsules Catalogue organisation: LILLY DEUTSCHLAND GmbH
-
80 mg · 56 capsules Catalogue organisation: LILLY DEUTSCHLAND GmbH
-
80 mg · 112 capsules Catalogue organisation: LILLY DEUTSCHLAND GmbH
OFFICIAL SOURCES
Check the Retsevmo record at an official source.
Search for “Retsevmo” or “Selpercatinib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Retsevmo.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Retsevmo
01What is Retsevmo?＋
This directory record associates the brand name Retsevmo with the active ingredient Selpercatinib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Retsevmo strengths and packs are recorded?＋
The catalogue currently shows: 40 mg · 56 capsules; 40 mg · 168 capsules; 80 mg · 56 capsules; 80 mg · 112 capsules. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Retsevmo?＋
Catalogue records currently name: LILLY DEUTSCHLAND GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Retsevmo?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Retsevmo, payment request, stock guarantee or binding offer.
06Can I buy Retsevmo from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.